vs
Side-by-side financial comparison of ENNIS, INC. (EBF) and AMICUS THERAPEUTICS, INC. (FOLD). Click either name above to swap in a different company.
AMICUS THERAPEUTICS, INC. is the larger business by last-quarter revenue ($185.2M vs $100.2M, roughly 1.8× ENNIS, INC.). ENNIS, INC. runs the higher net margin — 10.8% vs 0.9%, a 9.9% gap on every dollar of revenue. On growth, AMICUS THERAPEUTICS, INC. posted the faster year-over-year revenue change (23.7% vs 0.4%). AMICUS THERAPEUTICS, INC. produced more free cash flow last quarter ($16.0M vs $15.7M). Over the past eight quarters, AMICUS THERAPEUTICS, INC.'s revenue compounded faster (29.5% CAGR vs 1.4%).
ENNIS, INC. (ticker EBF) is a leading North American provider of printed business products and related services. Its offerings include custom business forms, pressure-sensitive labels, marketing collateral, promotional items, and branded packaging, serving clients across retail, healthcare, financial services, and small business segments.
Amicus Therapeutics, Inc. is a public American biopharmaceutical company based in Philadelphia, Pennsylvania. The company went public in 2007 under the Nasdaq trading symbol FOLD. This followed a 2006 planned offering and subsequent withdrawal, which would have established the trading symbol as AMTX Prior to their IPO, Amicus was funded by a variety of venture capital firms including Radius Ventures, Canaan Partners and New Enterprise Associates.
EBF vs FOLD — Head-to-Head
Income Statement — Q3 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $100.2M | $185.2M |
| Net Profit | $10.8M | $1.7M |
| Gross Margin | 31.9% | 85.7% |
| Operating Margin | 15.0% | 8.6% |
| Net Margin | 10.8% | 0.9% |
| Revenue YoY | 0.4% | 23.7% |
| Net Profit YoY | 6.1% | -88.5% |
| EPS (diluted) | $0.42 | $0.00 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $100.2M | $185.2M | ||
| Q3 25 | $98.7M | $169.1M | ||
| Q2 25 | $97.2M | $154.7M | ||
| Q1 25 | $92.7M | $125.2M | ||
| Q4 24 | $99.8M | $149.7M | ||
| Q3 24 | $99.0M | $141.5M | ||
| Q2 24 | $103.1M | $126.7M | ||
| Q1 24 | $97.4M | $110.4M |
| Q4 25 | $10.8M | $1.7M | ||
| Q3 25 | $13.2M | $17.3M | ||
| Q2 25 | $9.8M | $-24.4M | ||
| Q1 25 | $9.0M | $-21.7M | ||
| Q4 24 | $10.2M | $14.7M | ||
| Q3 24 | $10.3M | $-6.7M | ||
| Q2 24 | $10.7M | $-15.7M | ||
| Q1 24 | $10.1M | $-48.4M |
| Q4 25 | 31.9% | 85.7% | ||
| Q3 25 | 30.5% | 88.5% | ||
| Q2 25 | 31.1% | 90.2% | ||
| Q1 25 | 29.5% | 90.7% | ||
| Q4 24 | 29.3% | 90.1% | ||
| Q3 24 | 30.1% | 90.6% | ||
| Q2 24 | 30.0% | 91.1% | ||
| Q1 24 | 28.4% | 87.7% |
| Q4 25 | 15.0% | 8.6% | ||
| Q3 25 | 12.5% | 20.3% | ||
| Q2 25 | 13.7% | -6.1% | ||
| Q1 25 | 13.0% | -6.3% | ||
| Q4 24 | 13.1% | 10.7% | ||
| Q3 24 | 13.3% | 15.3% | ||
| Q2 24 | 13.3% | 11.8% | ||
| Q1 24 | 13.3% | -25.1% |
| Q4 25 | 10.8% | 0.9% | ||
| Q3 25 | 13.3% | 10.2% | ||
| Q2 25 | 10.1% | -15.8% | ||
| Q1 25 | 9.7% | -17.3% | ||
| Q4 24 | 10.2% | 9.8% | ||
| Q3 24 | 10.4% | -4.8% | ||
| Q2 24 | 10.4% | -12.4% | ||
| Q1 24 | 10.4% | -43.9% |
| Q4 25 | $0.42 | $0.00 | ||
| Q3 25 | $0.51 | $0.06 | ||
| Q2 25 | $0.38 | $-0.08 | ||
| Q1 25 | $0.34 | $-0.07 | ||
| Q4 24 | $0.39 | $0.05 | ||
| Q3 24 | $0.40 | $-0.02 | ||
| Q2 24 | $0.41 | $-0.05 | ||
| Q1 24 | $0.39 | $-0.16 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $31.3M | $293.5M |
| Total DebtLower is stronger | — | $392.7M |
| Stockholders' EquityBook value | $304.8M | $274.2M |
| Total Assets | $354.3M | $949.9M |
| Debt / EquityLower = less leverage | — | 1.43× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $31.3M | $293.5M | ||
| Q3 25 | $31.9M | $263.8M | ||
| Q2 25 | $32.6M | $231.0M | ||
| Q1 25 | $72.5M | $250.6M | ||
| Q4 24 | $68.6M | $249.9M | ||
| Q3 24 | $122.6M | $249.8M | ||
| Q2 24 | $123.7M | $260.1M | ||
| Q1 24 | $110.9M | $239.6M |
| Q4 25 | — | $392.7M | ||
| Q3 25 | — | $392.0M | ||
| Q2 25 | — | $391.3M | ||
| Q1 25 | — | $390.7M | ||
| Q4 24 | — | $390.1M | ||
| Q3 24 | — | $389.5M | ||
| Q2 24 | — | $388.9M | ||
| Q1 24 | — | $388.4M |
| Q4 25 | $304.8M | $274.2M | ||
| Q3 25 | $305.4M | $230.4M | ||
| Q2 25 | $301.2M | $204.3M | ||
| Q1 25 | $302.0M | $193.6M | ||
| Q4 24 | $297.7M | $194.0M | ||
| Q3 24 | $358.4M | $178.8M | ||
| Q2 24 | $354.4M | $132.5M | ||
| Q1 24 | $349.8M | $130.7M |
| Q4 25 | $354.3M | $949.9M | ||
| Q3 25 | $361.8M | $868.8M | ||
| Q2 25 | $361.7M | $815.3M | ||
| Q1 25 | $348.9M | $789.8M | ||
| Q4 24 | $346.1M | $785.0M | ||
| Q3 24 | $406.8M | $786.6M | ||
| Q2 24 | $406.2M | $749.5M | ||
| Q1 24 | $399.2M | $721.8M |
| Q4 25 | — | 1.43× | ||
| Q3 25 | — | 1.70× | ||
| Q2 25 | — | 1.92× | ||
| Q1 25 | — | 2.02× | ||
| Q4 24 | — | 2.01× | ||
| Q3 24 | — | 2.18× | ||
| Q2 24 | — | 2.93× | ||
| Q1 24 | — | 2.97× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $16.4M | $16.3M |
| Free Cash FlowOCF − Capex | $15.7M | $16.0M |
| FCF MarginFCF / Revenue | 15.7% | 8.6% |
| Capex IntensityCapex / Revenue | 0.7% | 0.2% |
| Cash ConversionOCF / Net Profit | 1.52× | 9.62× |
| TTM Free Cash FlowTrailing 4 quarters | $42.5M | $29.8M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $16.4M | $16.3M | ||
| Q3 25 | $10.5M | $35.7M | ||
| Q2 25 | $8.0M | $-26.5M | ||
| Q1 25 | $12.8M | $7.8M | ||
| Q4 24 | $18.2M | $-3.9M | ||
| Q3 24 | $11.8M | $-23.0M | ||
| Q2 24 | $23.1M | $22.7M | ||
| Q1 24 | $16.6M | $-29.7M |
| Q4 25 | $15.7M | $16.0M | ||
| Q3 25 | $9.0M | $35.3M | ||
| Q2 25 | $6.6M | $-28.9M | ||
| Q1 25 | $11.1M | $7.5M | ||
| Q4 24 | $17.5M | $-4.2M | ||
| Q3 24 | $10.7M | $-23.3M | ||
| Q2 24 | $20.6M | $21.6M | ||
| Q1 24 | $15.0M | $-31.5M |
| Q4 25 | 15.7% | 8.6% | ||
| Q3 25 | 9.2% | 20.9% | ||
| Q2 25 | 6.8% | -18.7% | ||
| Q1 25 | 12.0% | 6.0% | ||
| Q4 24 | 17.6% | -2.8% | ||
| Q3 24 | 10.8% | -16.5% | ||
| Q2 24 | 20.0% | 17.0% | ||
| Q1 24 | 15.3% | -28.5% |
| Q4 25 | 0.7% | 0.2% | ||
| Q3 25 | 1.4% | 0.2% | ||
| Q2 25 | 1.4% | 1.6% | ||
| Q1 25 | 1.8% | 0.2% | ||
| Q4 24 | 0.6% | 0.2% | ||
| Q3 24 | 1.1% | 0.3% | ||
| Q2 24 | 2.4% | 0.9% | ||
| Q1 24 | 1.7% | 1.6% |
| Q4 25 | 1.52× | 9.62× | ||
| Q3 25 | 0.80× | 2.06× | ||
| Q2 25 | 0.81× | — | ||
| Q1 25 | 1.41× | — | ||
| Q4 24 | 1.78× | -0.27× | ||
| Q3 24 | 1.15× | — | ||
| Q2 24 | 2.16× | — | ||
| Q1 24 | 1.63× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
EBF
Segment breakdown not available.
FOLD
| Other | $105.8M | 57% |
| Galafold | $64.8M | 35% |
| Pombiliti Opfolda | $14.6M | 8% |
